Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;17(7):387-388.
doi: 10.1038/s41574-021-00509-x.

Glucose-lowering treatments and COVID-19 mortality in T2DM

Samy Hadjadj  1 , Matthieu Wargny  2   3
Affiliations
Comment

Glucose-lowering treatments and COVID-19 mortality in T2DM

Samy Hadjadj et al. Nat Rev Endocrinol. 2021 Jul.

Abstract

The poor prognosis in patients with diabetes mellitus who contract COVID-19 urged physicians to question routine drug treatment for people with type 2 diabetes mellitus. What treatment should we prioritize? So far only observational studies are available, although complementary interventional studies are needed to address this issue.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Comment on

References

    1. Khunti K, et al. Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England. Lancet Diabetes Endocrinol. 2021;9:293–303. doi: 10.1016/S2213-8587(21)00050-4. - DOI - PMC - PubMed
    1. Lalau J-D, et al. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19. Diabetes Metab. 2020;47:101216. doi: 10.1016/j.diabet.2020.101216. - DOI - PMC - PubMed
    1. Kow CS, Hasan SS. Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis. J. Med. Virol. 2021;93:695–697. doi: 10.1002/jmv.26498. - DOI - PubMed
    1. Yu B, Li C, Sun Y, Wang DW. Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes. Cell Metab. 2021;33:65–77. doi: 10.1016/j.cmet.2020.11.014. - DOI - PMC - PubMed
    1. McGurnaghan SJ, et al. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. Lancet Diabetes Endocrinol. 2021;9:82–93. doi: 10.1016/S2213-8587(20)30405-8. - DOI - PMC - PubMed